Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial by Chiuppesi, Flavia, PhD, Zaia, John A, Prof, Frankel, Paul H, Prof, Stan, Rodica, PhD, Drake, Jennifer, RN, Williams, Brenda, RN, Acosta, Anne Marie, LVN, Francis, Karyn, RN, Taplitz, Randy A, Prof, Dickter, Janet K, MD, Dadwal, Sanjeet, MD, Puing, Alfredo G, MD, Nanayakkara, Deepa D, MD, Ash, Patricia, RN, Cui, Yujie, MS, Contreras, Heidi, PhD, La Rosa, Corinna, PhD, Tiemann, Katrin, PhD, Park, Yoonsuh, PhD, Medina, Joybelle, MS, Iniguez, Angelina, MS, Zhou, Qiao, MS, Karpinski, Veronica, MS, Johnson, Daisy, MS, Faircloth, Katelyn, MS, Kaltcheva, Teadora, PhD, Nguyen, Jenny, MS, Kha, Mindy, MS, Nguyen, Vu H, PhD, Francisco, Sandra Ortega, PhD, Grifoni, Alba, PhD, Wong, Angela, MS, Sette, Alessandro, PhD, Wussow, Felix, PhD, Diamond, Don J, Prof

Get full text